Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SERPINE1 | P05121 | 3/20 | 0.40 |
| ▸ | SCN1A | P35498 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1526930 | 0.77 | TDP1 (0.59) | KMT2AMAPTLMNAMEN1 | |
| SCHEMBL29317372 | 0.75 | ESR1 (0.50) | ESR1LMNASERPINE1CA2CA12 | |
| SCHEMBL28785734 | 0.73 | ESR1 (0.77) | ESR1MAPT | |
| SCHEMBL16248439 | 0.72 | SERPINE1 (0.53) | ESR1KMT2ASERPINE1CA2CA12 | |
| SCHEMBL14097158 | 0.72 | ESR1 (0.55) | ESR1LMNASERPINE1CA2CA12 | |
| SCHEMBL10066343 | 0.72 | SERPINE1 (0.53) | ESR1KMT2ALMNASERPINE1CA2 | |
| SCHEMBL16425823 | 0.71 | TSHR (0.47) | ESR1SERPINE1CA2CA12CA1 | |
| SCHEMBL22341753 | 0.71 | NPC1 (0.49) | ESR1KMT2AMAPTLMNASCN1A | |
| SCHEMBL29317288 | 0.70 | ESR1 (0.45) | ESR1LMNACA2CA12CA1 | |
| SCHEMBL9081898 | 0.69 | ALDH1A1 (0.43) | KMT2ALMNACA2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9464232-B2 | Compound, liquid crystal composition, polymer material, and film | FUJIFILM CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9383491-B2 | Retardation film, polarizing plate, and liquid crystal display | FUJIFILM CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| US-20160131809-A1 | PHASE DIFFERENCE FILM, POLARIZATION PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2016-05-12 | — | — | US | disclosed |
| US-20150029445-A1 | RETARDATION FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY | FUJIFILM CORPORATION (JP) | 2015-01-29 | — | — | US | disclosed |
| US-20140339470-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL, AND FILM | FUJIFILM CORPORATION (JP) | 2014-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140339470-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, POLYMER MATERIAL, AND FILM | CCL11, AQP1, FANCF | ESR1 4021/4885KMT2A 1956/4885MAPT 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.